-+ 0.00%
-+ 0.00%
-+ 0.00%

PSYENCE BIOMED HIGHLIGHTS RECENT PROGRESS ON ACTIVE PHASE IIB CLINICAL TRIAL

Reuters·12/17/2024 13:37:22

Please log in to view news